Severe sepsis is a complex process that involves a number of host immune responses with an orchestration of various specific and nonspecific soluble factors and cellular elements that may result in a completely different outcome. Among organ dysfunction induced by sepsis, heart failure can occur in up to 40% of cases \[[@B1]\]. Myocardial depression in shock probably was first described in 1947 \[[@B2]\]. Its onset may be extremely early, but is most evident in the first 3 days of the disease. Normalization usually happens over the following 7-10 days in the survivor patients \[[@B3]\]. We have described an atypical sort time reversible myocardial dysfunction, in a patient with rapid evolution to a multiple organ dysfunction syndrome (heart, renal, pulmonary, and hematological). An 87-year-old man with hypertension and diabetes mellitus type 2 was admitted to our intensive care unit (ICU) with severe sepsis caused by community-acquired pneumonia. On the following day of his ICU entrance he developed septic shock which was associated with an increase in the cardiac enzymes, particularly troponin I and CK mass (fluorogen immunoassay). We started the infusion of Xigris^®^, a recombinant version of human activated protein C, according to the PROWESS \[[@B4]\] protocol. His baseline examination characteristics before and 3 days after Xigris^®^infusion are summarized in Table [1](#T1){ref-type="table"}.

  Characteristic                       Admission   Pre-Xigris^®^infusion   3 days after end-infusion
  ------------------------------------ ----------- ----------------------- ---------------------------
  Troponin I (ng/ml) \< 0.4            1.1         1.6                     Normal
  CPK MB mass (ng/ml) \< 5             6.2         9.5                     Normal
  C-reactive protein (mg/dl) \< 1      36.3        38.7                    3.6
  Antithrombin (%)                     64          54                      89
  Protein C (%)                        62          48                      100
  D-dimer (mg/ml) \< 0.5               2.15        2.34                    3.28
  Thrombocytes                         98.000      81.000                  233.000
  B-type natriuretic peptide (pg/ml)   \> 1300                             1170
  Vasopressor therapy                  +/++++      ++++/++++               None
  Mechanical ventilation               None        ++++/++++               Weaning
  Echo dysfunction                     +/++++      ++++/++++               +/++++

The patient was discharged 10 days after the Xigris^®^end-of-infusion to a step-down unit. The physiology of the myocardial dysfunction that occurs in systemic inflammatory response syndrome is not well understood, although there are several theories to explain it \[[@B5]-[@B8]\]. We are reporting an unusual behavior of reversible nonischemic myocardial dysfunction possibly related to Xigris^®^treatment. Perhaps this communication could be tested in a well-designed study to address a new hypothesis for new applications of activated protein C outside the setting of severe sepsis.
